Distributor for

DUOPHARMA HAPI SDN BHD

Featured products of Duopharma HAPI

Artesto

Artesto tab 250 mg

abiraterone acetate

Packing/Price

120's

MIMS Class

Cancer Hormone Therapy

ATC Classification

L02BX03 - abiraterone : Belongs to the class of other hormone antagonists and related agents. Used in the treatment of metastatic castration-resistant prostate cancer.

Krabeva

Krabeva infusion conc 100 mg/4 mL

bevacizumab

Packing/Price

1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FG01 - bevacizumab : Belongs to the class of VEGF/VEGFR (Vascular Endothelial Growth Factor) inhibitors. Used in the treatment of cancer.

Krabeva infusion conc 400 mg/16 mL

bevacizumab

Packing/Price

1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FG01 - bevacizumab : Belongs to the class of VEGF/VEGFR (Vascular Endothelial Growth Factor) inhibitors. Used in the treatment of cancer.

Lebreta

Lebreta tab 2.5 mg

letrozole

Packing/Price

3 × 10's

MIMS Class

Cancer Hormone Therapy

ATC Classification

L02BG04 - letrozole : Belongs to the class of enzyme inhibitors. Used in treatment of neoplastic diseases.

Trexa

Trexa FC tab 250 mg

gefitinib

Packing/Price

30's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01EB01 - gefitinib : Belongs to the class of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors. Used in the treatment of cancer.

Distributor for Duopharma (M)

Kytron

Kytron soln for inj 3 mg/3 mL

granisetron hydrochloride

Packing/Price

10 × 1's

MIMS Class

Antiemetics, Supportive Care Therapy

ATC Classification

A04AA02 - granisetron : Belongs to the class of serotonin (5HT3) antagonists. Used for the prevention of nausea and vomiting.

Trevive

Trevive FC tab 100 mg

imatinib mesilate

Packing/Price

60's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01EA01 - imatinib : Belongs to the class of BCR-ABL tyrosine kinase inhibitors. Used in the treatment of cancer.

Trevive FC tab 400 mg

imatinib mesilate

Packing/Price

30's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01EA01 - imatinib : Belongs to the class of BCR-ABL tyrosine kinase inhibitors. Used in the treatment of cancer.